Co-Authors
This is a "connection" page, showing publications co-authored by Annamaria Iagnocco and Piero Ruscitti.
Connection Strength
1.347
-
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al. Ann Rheum Dis. 2020 Sep 09.
Score: 0.225
-
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. Ann Rheum Dis. 2020 09; 79(9):1152-1155.
Score: 0.223
-
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. Front Immunol. 2020; 11:1130.
Score: 0.221
-
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? Ann Rheum Dis. 2020 11; 79(11):1515-1516.
Score: 0.221
-
Cytokine storm syndrome in severe COVID-19. Autoimmun Rev. 2020 07; 19(7):102562.
Score: 0.220
-
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 08; 7(3).
Score: 0.060
-
Isolated "puffy hands" following COVID-19: clue to a long-term capillary leakage syndrome? Clin Rheumatol. 2021 09; 40(9):3863-3864.
Score: 0.060
-
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. Ann Rheum Dis. 2021 11; 80(11):1498-1501.
Score: 0.059
-
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1247-1254.
Score: 0.057